Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Classificação em ações #27536
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Preço da ação
$0.0416118
Valor de mercado
$32.25M
Variação (1 dia)
-1.67%
Variação (1 ano)
-59.58%
País
AU
Negociar Neurizon Therapeutics Limited (NUZ)

Categoria

Histórico de rendimento de dividendos para Neurizon Therapeutics Limited (NUZ)
O rendimento de dividendos (TTM) da Neurizon Therapeutics Limited (símbolo da ação: NUZ) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Neurizon Therapeutics Limited (NUZ) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH